Ubie Secures Significant Funding for AI-Driven Healthcare Expansion
Ubie, a pioneering platform in AI-driven and medically vetted healthcare, has announced a remarkable achievement, securing over $125 million in cumulative funding since its establishment in 2017. This latest funding round includes contributions from prominent global firms such as Google, JAPAN POST CAPITAL, NTT DOCOMO, and more.
Founded to enhance patient navigation within the healthcare system, Ubie utilizes advanced AI technology to direct individuals toward the most suitable medical care. The platform initially garnered attention with its Series C funding of $26.2 million in August 2022, bringing the total raised up to $59.8 million at that time. With a user base surpassing four million in the United States alone, Ubie's highly accurate Symptom Checker has seen an impressive 85% growth in monthly active users since the beginning of 2024.
Kota Kubo, Co-Founder and CEO, emphasized the growing recognition and understanding of Ubie’s contributions to both patients and providers within the healthcare ecosystem. He noted, "Our growth is multifaceted, supported both by an expanding customer base and partnerships with significant healthcare stakeholders. Our ongoing initiatives aim to enhance our offerings in the U.S. for patients and providers alike."
Focus on Generative AI and Provider Solutions
As part of its strategic growth, Ubie aims to integrate generative AI into its operations. The intent is to enrich patient education by supplying crucial information about diseases early in their healthcare journey. This feature will further augment the capabilities of the Symptom Checker, making it an even more effective tool for users seeking to understand their health concerns.
Additionally, Ubie is developing a dedicated provider solution after being accepted into the Mayo Clinic’s Platform Accelerate program. This acceptance grants Ubie access to refine its service using the anonymized data of approximately three million patients from the Mayo Clinic, enhancing the accuracy and functionality of its platform.
Global Reach and Innovative Solutions
Ubie's Symptom Checker currently boasts over 13 million users globally each month. In Japan, the company offers the Ubie Medical Navigator, which installs AI-powered patient intake systems in over 1,800 medical facilities. Another feature, Ubie for Pharma, collaborates with pharmaceutical firms to raise awareness about specific diseases and treatments.
By leveraging technological innovations and a vast network, Ubie strives to create a healthcare landscape where everyone can access appropriate medical care efficiently. The organization is actively pursuing synergies with both local and international corporations to build advanced healthcare solutions tailored to meet the varying needs of patients and providers.
About Ubie
Since its inception in 2017, Ubie has been committed to empowering individuals and healthcare professionals by providing critical tools for better health outcomes. Leveraging state-of-the-art disease prediction AI, Ubie directs millions of people toward the necessary medical attention through its accessible online Symptom Checker, while equipping over 1,800 healthcare organizations with clinical tools to facilitate better diagnostic procedures and health management.
For those interested in learning more about Ubie's impact and initiatives, you can visit their
website to experience their free Symptom Checker as well.